Valneva SE VALN
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -41.50%
- 1 year
- -39.51%
Ownership
- Institutions 1.16%
- Insiders 0.00%
- Public and other holders 98.8%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| General American Investors Company Inc | 0.44% | 354,361 | 1.43M | Sep 29, 2024 |
| Wells Fargo & Company | 0.27% | 215,907 | 872.26K | Sep 29, 2024 |
| AlphaCentric Advisors LLC | 0.15% | 118,000 | 476.72K | Sep 29, 2024 |
| Ironwood Investment Management, LLC | 0.03% | 25,022 | 101.09K | Sep 29, 2024 |
| Ridgewood Investments LLC | 0.00% | 550 | 2.22K | Sep 29, 2024 |
| Alphamark Advisors, Llc | 0.00% | 150 | 605 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| General American Investors Co | 0.44% | 354,361 | 1.43M | Sep 29, 2024 |
| Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 0.15% | 118,000 | 476.72K | Sep 29, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.00% | 359 | 1.45K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs VALN, and what each was last paid
Thomas Lingelbach, President, Chief Executive Officer & DirectorAverage age 53
| Name | Title | Pay | Age |
|---|---|---|---|
| Thomas Lingelbach | President, Chief Executive Officer & Director | €1.07M | 63 |
| Peter Buhler | Chief Financial Officer | €437K | 55 |
| Juan-Carlos Jaramillo | Chief Medical Officer | €423K | 54 |
| Dipal Patel | Chief Commercial Officer | €378K | 51 |
| Kendra Wergin | General Counsel & Corporate Secretary | — | 39 |
| Katrin Dubischar | Vice President & Program Director of Chikungunya Vaccine | — | — |
| Hanneke Schuitemaker | Chief Scientific Officer | — | 61 |
| Joshua Drumm | Vice President of Investor Relations | — | — |
| Vincent Dequenne | Chief Operating Officer | — | 59 |
| Laetitia Bachelot-Fontaine | Vice President of Global Communications & European Investor Relations | — | — |
| Petra Pesendorfer | Chief People Officer | — | 40 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
